JPRN-UMIN000007115
Recruiting
未知
Clinical outcomes of Japanese rheumatoid arthritis patients in real world commencing targeted therapy (CORRECT) - CORRECT study
ConditionsRheumatoid arthritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Rheumatoid arthritis
- Sponsor
- Tokyo Medical and Dental University
- Enrollment
- 2000
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •A patient who has any of the following will be excluded from our study. 1\. When a patient withdraw consent to this study 2\. When a patient is participating in a clinical trial for approval of drugs at the enrollment. 3\. When a patient is regarded as inappropriate to join the study based on medical reasons or other rational reasons by attending physicians' discretion.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritisJPRN-UMIN000016950Osaka Medical College50
Completed
Not Applicable
Registry of Japanese Rheumatoid Arthritis Patients on Biologics for Long-term Safety (REAL)rheumatoid arthritisJPRN-UMIN000001222Department of Pharmacovigilance, Tokyo Medical and Dental University2,000
Recruiting
Phase 3
Outcome of Rheumatoid Arthritits patients following adjunct statin therapyHealth Condition 1: null- Diagnosed Rheumatoid Arthritis patients with active diseaseCTRI/2014/12/005233Kalinga Institute of Medical Sciences60
Completed
Not Applicable
Retention rate of iguratimod with and without methotrexate in patients with rheumatoid arthritis.JPRN-UMIN000041767Department of Hematology and Rheumatology, Kindai University School of Medicine106
Recruiting
Not Applicable
Corrona Japan Rheumatoid Arthritis (RA) RegistryRheumatoid ArthritisJPRN-UMIN000021394CorEvitas, LLC2,600